140 related articles for article (PubMed ID: 14648716)
21. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
Bower M; Nelson M; Young AM; Thirlwell C; Newsom-Davis T; Mandalia S; Dhillon T; Holmes P; Gazzard BG; Stebbing J
J Clin Oncol; 2005 Aug; 23(22):5224-8. PubMed ID: 16051964
[TBL] [Abstract][Full Text] [Related]
22. AIDS-associated Kaposi's sarcoma in Northeastern Nigeria.
Kagu MB; Nggada HA; Garandawa HI; Askira BH; Durosinmi MA
Singapore Med J; 2006 Dec; 47(12):1069-74. PubMed ID: 17139404
[TBL] [Abstract][Full Text] [Related]
23. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
24. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy.
Aboulafia DM
Mayo Clin Proc; 1998 May; 73(5):439-43. PubMed ID: 9581584
[TBL] [Abstract][Full Text] [Related]
25. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
[TBL] [Abstract][Full Text] [Related]
26. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study.
Martró E; Esteve A; Schulz TF; Sheldon J; Gambús G; Muñoz R; Whitby D; Casabona J;
Int J Cancer; 2007 Mar; 120(5):1129-35. PubMed ID: 17154170
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.
Yoshioka MC; Alchorne MM; Porro AM; Tomimori-Yamashita J
Int J Dermatol; 2004 Sep; 43(9):643-7. PubMed ID: 15357742
[TBL] [Abstract][Full Text] [Related]
29. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis.
Mori S; Murakami-Mori K; Jewett A; Nakamura S; Bonavida B
Cancer Res; 1996 Apr; 56(8):1874-9. PubMed ID: 8620507
[TBL] [Abstract][Full Text] [Related]
30. Spectrum of Kaposi's sarcoma in the epidemic of AIDS.
Safai B; Sarngadharan MG; Koziner B; Godbold J; Myskowski PL; Cunningham-Rundles S; Johnson K; Gold J; Krown S; Dupont B
Cancer Res; 1985 Sep; 45(9 Suppl):4646s-4648s. PubMed ID: 2990700
[TBL] [Abstract][Full Text] [Related]
31. Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1. The Multicenter AIDS Cohort Study Group.
Jacobson LP; Muñoz A; Fox R; Phair JP; Dudley J; Obrams GI; Kingsley LA; Polk BF
J Acquir Immune Defic Syndr (1988); 1990; 3 Suppl 1():S24-31. PubMed ID: 2395082
[TBL] [Abstract][Full Text] [Related]
32. Relationship of serum levels of oncostatin M to AIDS-related and classic Kaposi's sarcoma.
Hamilton AS; Radka SF; Bernstein L; Gill PS; Gonsalves M; Naemura JR; Ross RK
J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):410-4. PubMed ID: 7907664
[TBL] [Abstract][Full Text] [Related]
33. AIDS-related Kaposi's sarcoma in a patient with a normal CD4 count.
Power DG; Mulholland PJ; O'Byrne KJ
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):97. PubMed ID: 17954026
[No Abstract] [Full Text] [Related]
34. Kaposi's sarcoma: a reevaluation.
Orfanos CE; Husak R; Wölfer U; Garbe C
Recent Results Cancer Res; 1995; 139():275-96. PubMed ID: 7541146
[TBL] [Abstract][Full Text] [Related]
35. [T-helper (CD4+) cytopenia and HLA-A1, -B8, -C27, -DR3].
Kuntz BM; Sobieraj B; Brüster HT
Beitr Infusionsther Transfusionsmed; 1994; 32():310-3. PubMed ID: 9480115
[TBL] [Abstract][Full Text] [Related]
36. Presentation of AIDS-related pulmonary Kaposi's sarcoma diagnosed by bronchoscopy.
Huang L; Schnapp LM; Gruden JF; Hopewell PC; Stansell JD
Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1385-90. PubMed ID: 8616570
[TBL] [Abstract][Full Text] [Related]
37. Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis.
Mallery SR; Bailer RT; Hohl CM; Ng-Bautista CL; Ness GM; Livingston BE; Hout BL; Stephens RE; Brierley GP
J Cell Biochem; 1995 Nov; 59(3):317-28. PubMed ID: 8567750
[TBL] [Abstract][Full Text] [Related]
38. NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma.
Goodier MR; Mela CM; Steel A; Gazzard B; Bower M; Gotch F
J Virol; 2007 Jan; 81(1):430-3. PubMed ID: 17035308
[TBL] [Abstract][Full Text] [Related]
39. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
40. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
